Insiders · Profile

PFREUNDSCHUH PETER P.

Chief Financial Officer at Voyager Therapeutics · Chief Financial Officer at Korro Bio · Chief Financial Officer at UroGen Pharma. Filing since 20 Aug 2019. CIK 0001585839

Company
Date
Role
Action
Shares
Amount
Of holding
21 Feb 2024
Chief Financial Officer
Sold at will
3,764
$28.08K
2.1%
3 Oct 2023
Chief Financial Officer
Sold at will
13,567
$94.83K
8.3%
22 Feb 2022
Chief Financial Officer
Sold, plan not stated
1,542
$5.44K
14.7%
18 Feb 2022
Chief Financial Officer
Sold, plan not stated
1,404
$5.44K
11.8%
17 Feb 2022
Chief Financial Officer
Sold, plan not stated
1,296
$5.44K
9.8%
16 Feb 2022
Chief Financial Officer
Sold, plan not stated
1,229
$5.44K
8.5%
15 Feb 2022
Chief Financial Officer
Sold, plan not stated
1,347
$5.83K
8.6%
15 Oct 2020
Chief Financial Officer
Sold, plan not stated
2,400
$52.25K
18.7%
1 Sep 2020
Chief Financial Officer
Sold, plan not stated
509
$11.62K
6.1%
27 Jul 2020
Chief Financial Officer
Sold, plan not stated
141
$3.31K
1.9%
20 May 2020
Chief Financial Officer
Sold, plan not stated
358
$8.98K
4.8%
27 Apr 2020
Chief Financial Officer
Sold, plan not stated
141
$3.43K
2.2%
20 Feb 2020
Chief Financial Officer
Sold, plan not stated
360
$10.68K
5.6%
27 Jan 2020
Chief Financial Officer
Sold, plan not stated
667
$19.53K
13.1%
20 Nov 2019
Chief Financial Officer
Sold, plan not stated
354
$10.06K
9.3%
20 Aug 2019
Chief Financial Officer
Sold, plan not stated
1,416
$46.83K
34.0%
16 decisions on file.